ArticleActive
Billing and Coding: MolDX: Pharmacogenomics Testing
A57174
Updated: December 31, 2025
Policy Summary
This policy provides billing and coding instructions for reporting MolDX pharmacogenomics testing: submit the appropriate CPT code with 1 unit of service, report the applicable ICD-10-CM diagnosis code, and include the DEX Z-Code identifier adjacent to the CPT in the specified comment/narrative fields for Part A and Part B claim types. It supplements LCD DL38394 and does not define medical necessity or coverage determinations.
Coverage Criteria Preview
Key requirements from the full policy
"This billing and coding guidance complements LCD MolDX: Pharmacogenomics Testing (DL38394) and does not itself determine medical necessity or coverage."
Sign up to see full coverage criteria, indications, and limitations.